Reduced red cell transfusions and hospitalizations in sickle cell patients treated with voxelotor-Experience from a single center

Transfusion. 2022 Jul;62(7):1462-1464. doi: 10.1111/trf.16989.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anemia, Sickle Cell* / therapy
  • Antisickling Agents
  • Benzaldehydes*
  • Hospitalization
  • Humans
  • Pyrazines
  • Pyrazoles

Substances

  • Antisickling Agents
  • Benzaldehydes
  • Pyrazines
  • Pyrazoles
  • voxelotor